欢迎访问行业研究报告数据库

报告分类

重点报告推荐

当前位置:首页 > 行业导航

找到报告 33926 篇 当前为第 198 页 共 3393

所属行业:医药制造业

  • 1971.全球血液动力学监测设备市场(2021-2030年)

    [电气机械和器材制造业,医药制造业,专用设备制造业] [2021-10-27]

    The scope of the research study titled global hemodynamic monitoring devices market is aimed at assessing the market potential of various hemodynamic monitoring devices. The following were the types of approaches in which the global hemodynamic monitoring devices market was estimated and its growth potential for the forecast period was evaluated:

    关键词:全球血流动力学;监测设备;市场潜力;增长潜力
  • 1972.全球肝素市场报告(2021-2028年)

    [医药制造业] [2021-10-27]

    Heparin is an anticoagulant medication and a naturally occurring glycosaminoglycan produced by basophils and mast cells in all mammals. Heparin is used to prevent formation of blood clots caused by certain medical conditions or medical procedures. The report provides market dynamics and trends related to the global heparin market. The study estimates the revenue generated from the sales of heparin products; however, it excludes the heparin products service revenue. The valuations comprise revenue generated from heparin products such as unfractionated heparin, low molecular weight heparin, and ultra-low molecular weight heparin.

    关键词:肝素;抗凝药物;嗜碱性粒细胞;天然糖胺聚糖;肥大细胞;医疗程序
  • 1973.全球健康保险市场(2021-2028年)

    [医药制造业,信息传输、软件和信息技术服务业] [2021-10-27]

    Health insurance covers medical expenses incurred during treatment of any disease, injury, or other mental & physical impairment. It acts as compensation in exchange for a monthly/semi-annual/annual premium or a payroll tax to provide healthcare benefits. The insurer is obliged to cover medical expenses for the policy holder up till the tenure and coverage of the policy. Depending on the policy, the coverage may vary for numerous factors, including diseases, age group, government policies, and others.

    关键词:健康保险;任何疾病;伤害;医疗费用;身体障碍;医疗福利;医疗费用
  • 1974.医药生物行业:深入推广三明医改模式,以下领域有望受益-简评报告

    [医药制造业] [2021-10-24]

    10 月15 日,国务院医改领导小组印发《关于深入推广福建省三明市经验深化医药卫生体制改革的实施意见》。文件紧密围绕医疗联合体建设,从药耗集采、医疗服务价格调整、医务人员薪酬制度改革、医保支付方式改革等领域提出实施意见。

    关键词:医药生物;三明医改模式;医疗联合体建设;
  • 1975.医药行业:制药上游,替代升级-全球龙头系列报告之四

    [医药制造业] [2021-10-24]

    产品升级、国产替代。制药上游装备/试剂公司处在产业升级的关键节点,2020-2021年全球新冠疫情中,部分国产制药装备、科研试剂公司把握了需求快速增长&升级的窗口期,缩小与海外公司差距。后疫情阶段,我们认为国产替代、需求升级(新技术、新市场)驱动上游装备/试剂公司产品升级“长牛”空间。

    关键词:医药行业;制药;国产药品
  • 1976.生物制品行业:后疫情时代,国内疫苗企业分化加速-新冠促进中国疫苗产业全面升级

    [医药制造业] [2021-10-24]

    中国疫苗产业通过新冠疫情防控从资金实力、国内疫苗产业链配套、人才队伍和国际化等方面得到全面提升。同时疫情后时代国内疫苗企业也将迎来进一步分化。

    关键词:疫苗产业;后疫情时代;疫苗法;国际化进程
  • 1977.全球女性健康市场展望和预测(2021-2026年)

    [医药制造业] [2021-10-24]

    Women’s health makes only 4% of the overall funding that goes into the research and development of healthcare products and services. Most of the spending on diseases is male-specific. Male-specific conditions such as prostate cancer account for around 2% of the overall funding. Today, women account for 49.6% of the total population across the world. The economic burden on women-specific diseases has reached over $500 billion. Healthcare should become personalized and patient-centric, which, in turn, increases the demand for management and delivery of healthcare to be genderneutral. For several decades, healthcare products and solutions were designed, developed, and delivered without much attention to the fact that healthcare needs are different for men and women, considering their physiological differences. There is an urgent need for building different products for women and find solutions that are specific to the physiology of women. As there are fundamental differences in the process of metabolizing drugs for women and men, inclusion of women in product development, clinical trials, research, and marketing has become essential. Currently, a wave of change has emerged in healthcare companies that are increasingly recognizing the need to serve women better.

    关键词:女性健康;医疗保健产品和服务;女性特有疾病;个性化;以患者为中心;医疗保健管理和交付;医疗保健产品;解决方案
  • 1978.全球手术室市场分析和预测中人工智能 AI(2021-2030年)

    [医药制造业,仪器仪表制造业,计算机、通信和其他电子设备制造业] [2021-10-24]

    The global AI in operating room market is in the initial stages with significant potential for growth during the forecast period, 2021-2030. The current market landscape involves hardware and software solutions that are deployed in operating rooms with AI and computer vision technology supporting the surgical teams to improve the output with added safety. The current barriers for conventional operations include factors such as lack of resources, training, languages, staff turnover, and the available skill level. AI solutions deployed in the operating room can stay up to date with surgical events and cross-check them with a large database of information. Thus, it can aid the surgical team in planning the next steps and predict outcomes. There are other types of algorithms that perform other functions, such as operating room management, scheduling, and tracking.

    关键词:手术室市场全球人工智能;增长潜力;硬件和软件;手术室解决方案;人工智能;计算机视觉技术;提高输出;增加安全性
  • 1979.全球OTC人工滴眼液市场报告(2021-2028年)

    [医药制造业] [2021-10-24]

    Artificial tears drug is used for the treatment of dry eye syndrome and allergic conjunctivitis. OTC artificial tears help to maintain moisture and well-being mostly in geriatric patients, who are vulnerable to dry eye syndrome due to intake of many medications and dysfunctions of lacrimal gland. This study comprises products only and not the services. The study estimates the revenue generated from the sales of OTC artificial tears. The valuations comprise revenue generated from adoption of OTC artificial tears by patients. The study scope focuses on OTC artificial drugs for hospital pharmacies, drug stores, and online pharmacies.

    关键词:人工泪液药物;治疗干眼症;过敏性结膜炎;帮助保持水分和健康;医院药房;药店;人工药物
  • 1980.医药生物行业:从百普赛斯上市看生物试剂行业-专题报告

    [医药制造业] [2021-10-22]

    2021 年10 月18 日,百普赛斯于创业板上市,生物试剂行业迎来新标 的。作为生物试剂重组蛋白细分龙头,如何看待行业的整体空间、公司 的成长路径及当前龙头公司的发展是本篇报告主要聚焦的方向。

    关键词:医药生物行业;百普赛斯;生物试剂
首页  上一页  ...  193  194  195  196  197  198  199  200  201  202  ...  下一页  尾页  
© 2016 武汉世讯达文化传播有限责任公司 版权所有
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服